Evidence map›Paper›PMID 26150392›Full record

ArticleThe Journal of cell biology2015

Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves.

Jose A Gomez-Sanchez, Lucy Carty, Marta Iruarrizaga-Lejarreta, Marta Palomo-Irigoyen, Marta Varela-Rey, Megan Griffith, Janina Hantke, Nuria Macias-Camara, Mikel Azkargorta, Igor Aurrekoetxea and 11 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in The Journal of cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03689257 (Prospective and Multicenter Study About the Epidemiology and the Characteristics "Omics" in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain), which is not on this map. Cited by 260 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
260citing papers in PubMed, 1 pooled it
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03689257 completednot on this mapstarted 2017, after this paper: background citation

Prospective and Multicenter Study About the Epidemiology and the Characteristics "Omics" in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain

TypeobservationalSponsorFundación de Investigación Biomédica - Hospital Universitario de La PrincesaRan2017 to 2020Enrolled376ConditionsInflammatory Bowel Diseases
3 · Its place in the literature

Who cites it

260 citing papers in PubMed, 1 synthesis or guideline pooled it, 460 citations in OpenAlex.

  1. Guideline
  2. Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy.Annals of clinical and translational neurology · 2024
    Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Beneficially Stressing the Peripheral Nervous System to Repair.International journal of molecular sciences · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

200 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 3 countries.

Jose A Gomez-SanchezDepartment of Cell and Developmental Biology, University College London, London WC1E 6BT, England, UK.
Lucy CartyDepartment of Cell and Developmental Biology, University College London, London WC1E 6BT, England, UK.
Marta Iruarrizaga-LejarretaCIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160 Derio, Bizkaia, Spain.
Marta Palomo-IrigoyenCIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160 Derio, Bizkaia, Spain.
Marta Varela-ReyCIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160 Derio, Bizkaia, Spain.
Megan GriffithDepartment of Cell and Developmental Biology, University College London, London WC1E 6BT, England, UK.
Janina HantkeDepartment of Cell and Developmental Biology, University College London, London WC1E 6BT, England, UK.
Nuria Macias-CamaraCIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160 Derio, Bizkaia, Spain.
Mikel AzkargortaCIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160 Derio, Bizkaia, Spain ProteoRed-ISCIII.
Igor AurrekoetxeaDepartment of Physiology, Faculty of Medicine and Dentistry, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain Biocruces Health Research Institute, 48903 Barakaldo, Spain.
Virginia Gutiérrez De JuanCIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160 Derio, Bizkaia, Spain.
Harold B J JefferiesThe Francis Crick Institute, Lincoln's Inn Fields Laboratory, London WC2A 3LY, England, UK.
Patricia AspichuetaDepartment of Physiology, Faculty of Medicine and Dentistry, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain Biocruces Health Research Institute, 48903 Barakaldo, Spain.
Félix ElortzaCIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160 Derio, Bizkaia, Spain ProteoRed-ISCIII.
Ana M AransayCIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160 Derio, Bizkaia, Spain.
María L Martínez-ChantarCIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160 Derio, Bizkaia, Spain Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), E-48080 Bilbao, Spain.
Frank BaasDepartment of Genome Analysis, Academic Medical Centre, 1105 AZ Amsterdam, Netherlands.
José M MatoCIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160 Derio, Bizkaia, Spain.
Rhona MirskyDepartment of Cell and Developmental Biology, University College London, London WC1E 6BT, England, UK.
Ashwin WoodhooCIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160 Derio, Bizkaia, Spain Ikerbasque, Basque Foundation for Science, 48011 Bilbao, Spain awoodhoo@cicbiogune.es k.jessen@ucl.ac.uk.
Kristján R JessenDepartment of Cell and Developmental Biology, University College London, London WC1E 6BT, England, UK awoodhoo@cicbiogune.es k.jessen@ucl.ac.uk.
CIC bioGUNE · ESUniversity College London · GBCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESBioCruces Health research Institute · ESAcademic Medical Center · NLIkerbasque · ESThe Francis Crick Institute · GB

Funding

Role of SAMe in Pathogenesis and Treatment of Non-Alcholic Fatty Liver DiseaseR01AT001576 · NCCIH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LU, SHELLY CHI-LOO · 2002 to 2018
$5.0M
Cancer Research UK 15153Medical Research Council G0600967NCCIH NIH HHS R01 AT001576Wellcome Trust
6 · The paper itself

Abstract

Although Schwann cell myelin breakdown is the universal outcome of a remarkably wide range of conditions that cause disease or injury to peripheral nerves, the cellular and molecular mechanisms that make Schwann cell-mediated myelin digestion possible have not been established. We report that Schwann cells degrade myelin after injury by a novel form of selective autophagy, myelinophagy. Autophagy was up-regulated by myelinating Schwann cells after nerve injury, myelin debris was present in autophagosomes, and pharmacological and genetic inhibition of autophagy impaired myelin clearance. Myelinophagy was positively regulated by the Schwann cell JNK/c-Jun pathway, a central regulator of the Schwann cell reprogramming induced by nerve injury. We also present evidence that myelinophagy is defective in the injured central nervous system. These results reveal an important role for inductive autophagy during Wallerian degeneration, and point to potential mechanistic targets for accelerating myelin clearance and improving demyelinating disease.

Indexed as

AutophagyAnimalsCells, CulturedJNK Mitogen-Activated Protein KinasesLipid MetabolismMice, TransgenicMyelin SheathPeripheral Nerve InjuriesProto-Oncogene Proteins c-junSciatic NerveTOR Serine-Threonine KinasesWallerian DegenerationJNK Mitogen-Activated Protein KinasesmTOR protein, mouseProto-Oncogene Proteins c-junTOR Serine-Threonine Kinases

Identifiers

PMID26150392
PMCPMC4494002
OpenAlexW1655540037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.